EA033752B1 - Способ определения по меньшей мере части генома плода на основе анализа материнского биологического образца - Google Patents
Способ определения по меньшей мере части генома плода на основе анализа материнского биологического образца Download PDFInfo
- Publication number
- EA033752B1 EA033752B1 EA201200690A EA201200690A EA033752B1 EA 033752 B1 EA033752 B1 EA 033752B1 EA 201200690 A EA201200690 A EA 201200690A EA 201200690 A EA201200690 A EA 201200690A EA 033752 B1 EA033752 B1 EA 033752B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- loci
- alleles
- genome
- inherited
- fetus
- Prior art date
Links
- 230000008774 maternal effect Effects 0.000 title claims abstract description 235
- 230000001605 fetal effect Effects 0.000 title claims abstract description 228
- 238000000034 method Methods 0.000 title claims abstract description 129
- 239000012472 biological sample Substances 0.000 title claims description 51
- 108700028369 Alleles Proteins 0.000 claims abstract description 343
- 102000054766 genetic haplotypes Human genes 0.000 claims abstract description 290
- 238000004458 analytical method Methods 0.000 claims abstract description 130
- 238000012163 sequencing technique Methods 0.000 claims abstract description 117
- 230000008775 paternal effect Effects 0.000 claims abstract description 89
- 230000035772 mutation Effects 0.000 claims abstract description 56
- 210000003754 fetus Anatomy 0.000 claims description 233
- 150000007523 nucleic acids Chemical class 0.000 claims description 124
- 102000039446 nucleic acids Human genes 0.000 claims description 117
- 108020004707 nucleic acids Proteins 0.000 claims description 117
- 210000000349 chromosome Anatomy 0.000 claims description 94
- 238000009826 distribution Methods 0.000 claims description 38
- 108090000623 proteins and genes Proteins 0.000 claims description 32
- 238000007847 digital PCR Methods 0.000 claims description 13
- 230000004807 localization Effects 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 8
- 238000002493 microarray Methods 0.000 claims description 5
- 238000004590 computer program Methods 0.000 claims description 4
- 238000004949 mass spectrometry Methods 0.000 claims description 4
- 238000009396 hybridization Methods 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 claims 1
- 239000012634 fragment Substances 0.000 abstract description 51
- 108020004414 DNA Proteins 0.000 description 212
- 102000053602 DNA Human genes 0.000 description 212
- 239000000523 sample Substances 0.000 description 78
- 210000004027 cell Anatomy 0.000 description 37
- 230000002068 genetic effect Effects 0.000 description 37
- 238000013459 approach Methods 0.000 description 19
- 238000001712 DNA sequencing Methods 0.000 description 15
- 238000003205 genotyping method Methods 0.000 description 14
- 239000002773 nucleotide Substances 0.000 description 14
- 125000003729 nucleotide group Chemical group 0.000 description 14
- 230000006798 recombination Effects 0.000 description 14
- 238000005215 recombination Methods 0.000 description 14
- 238000003752 polymerase chain reaction Methods 0.000 description 12
- 102000054765 polymorphisms of proteins Human genes 0.000 description 11
- 238000004364 calculation method Methods 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 108020004705 Codon Proteins 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000001623 nucleosome Anatomy 0.000 description 9
- 238000003793 prenatal diagnosis Methods 0.000 description 9
- 208000026350 Inborn Genetic disease Diseases 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- 108010047956 Nucleosomes Proteins 0.000 description 8
- 238000012217 deletion Methods 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000016361 genetic disease Diseases 0.000 description 8
- 125000005647 linker group Chemical group 0.000 description 8
- 206010071602 Genetic polymorphism Diseases 0.000 description 7
- 108010033040 Histones Proteins 0.000 description 7
- 102000006947 Histones Human genes 0.000 description 7
- 238000013507 mapping Methods 0.000 description 7
- 230000035935 pregnancy Effects 0.000 description 7
- 238000003556 assay Methods 0.000 description 6
- 238000004422 calculation algorithm Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000037430 deletion Effects 0.000 description 6
- 230000007067 DNA methylation Effects 0.000 description 5
- 208000005980 beta thalassemia Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000003753 real-time PCR Methods 0.000 description 5
- 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 208000036878 aneuploidy Diseases 0.000 description 4
- 231100001075 aneuploidy Toxicity 0.000 description 4
- 230000002759 chromosomal effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000012109 statistical procedure Methods 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 201000003883 Cystic fibrosis Diseases 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001114 immunoprecipitation Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229920002477 rna polymer Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- 208000009292 Hemophilia A Diseases 0.000 description 2
- 208000024556 Mendelian disease Diseases 0.000 description 2
- 108700011259 MicroRNAs Proteins 0.000 description 2
- 101150084935 PTER gene Proteins 0.000 description 2
- 108091027967 Small hairpin RNA Proteins 0.000 description 2
- 210000002593 Y chromosome Anatomy 0.000 description 2
- 201000006288 alpha thalassemia Diseases 0.000 description 2
- 208000025341 autosomal recessive disease Diseases 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 210000002230 centromere Anatomy 0.000 description 2
- 210000004252 chorionic villi Anatomy 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 238000012350 deep sequencing Methods 0.000 description 2
- 230000001973 epigenetic effect Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000002679 microRNA Substances 0.000 description 2
- 230000000869 mutational effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 210000004976 peripheral blood cell Anatomy 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 208000007056 sickle cell anemia Diseases 0.000 description 2
- 239000004055 small Interfering RNA Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000003411 telomere Anatomy 0.000 description 2
- 102000055501 telomere Human genes 0.000 description 2
- 108091035539 telomere Proteins 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002993 trophoblast Anatomy 0.000 description 2
- 101710145299 Biotin-[acetyl-CoA-carboxylase] ligase Proteins 0.000 description 1
- 102100033743 Biotin-[acetyl-CoA-carboxylase] ligase Human genes 0.000 description 1
- 101150029409 CFTR gene Proteins 0.000 description 1
- 206010008723 Chondrodystrophy Diseases 0.000 description 1
- 208000011359 Chromosome disease Diseases 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 description 1
- 201000010374 Down Syndrome Diseases 0.000 description 1
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
- 201000003542 Factor VIII deficiency Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 108010068323 Hemoglobin E Proteins 0.000 description 1
- 208000035920 Hemoglobin E disease Diseases 0.000 description 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 102100039869 Histone H2B type F-S Human genes 0.000 description 1
- 101000871771 Homo sapiens Biotin-[acetyl-CoA-carboxylase] ligase Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 101001035372 Homo sapiens Histone H2B type F-S Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 108091036060 Linker DNA Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100030569 Nuclear receptor corepressor 2 Human genes 0.000 description 1
- 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 208000004286 Osteochondrodysplasias Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108030004154 Propionyl-CoA carboxylases Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 206010044688 Trisomy 21 Diseases 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007844 allele-specific PCR Methods 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000007622 bioinformatic analysis Methods 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000004850 capillary HPLC Methods 0.000 description 1
- 208000014884 cartilage development disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007451 chromatin immunoprecipitation sequencing Methods 0.000 description 1
- 208000024971 chromosomal disease Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000003485 founder effect Effects 0.000 description 1
- 238000007672 fourth generation sequencing Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000006543 gametophyte development Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 208000034737 hemoglobinopathy Diseases 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000002998 immunogenetic effect Effects 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 208000018337 inherited hemoglobinopathy Diseases 0.000 description 1
- 102000008371 intracellularly ATP-gated chloride channel activity proteins Human genes 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000005059 placental tissue Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 210000003765 sex chromosome Anatomy 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 101150065190 term gene Proteins 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Software Systems (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25856709P | 2009-11-05 | 2009-11-05 | |
| US25907509P | 2009-11-06 | 2009-11-06 | |
| US38185410P | 2010-09-10 | 2010-09-10 | |
| PCT/US2010/055655 WO2011057094A1 (en) | 2009-11-05 | 2010-11-05 | Fetal genomic analysis from a maternal biological sample |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201200690A1 EA201200690A1 (ru) | 2013-05-30 |
| EA033752B1 true EA033752B1 (ru) | 2019-11-21 |
Family
ID=43500337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201200690A EA033752B1 (ru) | 2009-11-05 | 2010-11-05 | Способ определения по меньшей мере части генома плода на основе анализа материнского биологического образца |
Country Status (24)
| Country | Link |
|---|---|
| US (5) | US8467976B2 (enExample) |
| EP (5) | EP2496717B1 (enExample) |
| JP (3) | JP5540105B2 (enExample) |
| CN (2) | CN102770558B (enExample) |
| AU (1) | AU2010315037B9 (enExample) |
| BR (1) | BR112012010694B8 (enExample) |
| CA (1) | CA2779695C (enExample) |
| CY (1) | CY1122003T1 (enExample) |
| DK (3) | DK3783110T3 (enExample) |
| EA (1) | EA033752B1 (enExample) |
| ES (3) | ES2628874T3 (enExample) |
| FI (1) | FI3783110T3 (enExample) |
| HR (2) | HRP20230134T1 (enExample) |
| HU (3) | HUE034854T2 (enExample) |
| IL (3) | IL219521A (enExample) |
| LT (2) | LT3241914T (enExample) |
| MX (3) | MX2012005214A (enExample) |
| PL (3) | PL3783110T3 (enExample) |
| PT (3) | PT2496717T (enExample) |
| RS (2) | RS58879B1 (enExample) |
| SI (2) | SI3783110T1 (enExample) |
| SM (2) | SMT201900229T1 (enExample) |
| TW (1) | TWI458976B (enExample) |
| WO (1) | WO2011057094A1 (enExample) |
Families Citing this family (213)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US8532930B2 (en) | 2005-11-26 | 2013-09-10 | Natera, Inc. | Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals |
| AU2007220991C1 (en) | 2006-02-28 | 2013-08-15 | University Of Louisville Research Foundation | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
| US8609338B2 (en) | 2006-02-28 | 2013-12-17 | University Of Louisville Research Foundation, Inc. | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
| US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
| US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
| US9218449B2 (en) | 2007-07-23 | 2015-12-22 | The Chinese University Of Hong Kong | Methods for analyzing massively parallel sequencing data for noninvasive prenatal diagnosis |
| US20110033862A1 (en) * | 2008-02-19 | 2011-02-10 | Gene Security Network, Inc. | Methods for cell genotyping |
| EP2271772B1 (en) * | 2008-03-11 | 2014-07-16 | Sequenom, Inc. | Nucleic acid-based tests for prenatal gender determination |
| WO2009146335A1 (en) * | 2008-05-27 | 2009-12-03 | Gene Security Network, Inc. | Methods for embryo characterization and comparison |
| CA3116156C (en) | 2008-08-04 | 2023-08-08 | Natera, Inc. | Methods for allele calling and ploidy calling |
| US8962247B2 (en) * | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
| US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| US9524369B2 (en) | 2009-06-15 | 2016-12-20 | Complete Genomics, Inc. | Processing and analysis of complex nucleic acid sequence data |
| WO2011041485A1 (en) | 2009-09-30 | 2011-04-07 | Gene Security Network, Inc. | Methods for non-invasive prenatal ploidy calling |
| WO2011057094A1 (en) | 2009-11-05 | 2011-05-12 | The Chinese University Of Hong Kong | Fetal genomic analysis from a maternal biological sample |
| JP2013511991A (ja) * | 2009-11-25 | 2013-04-11 | クアンタライフ， インコーポレイテッド | 遺伝子材料を検出する方法および組成物 |
| EP3088532B1 (en) | 2009-12-22 | 2019-10-30 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
| US8700341B2 (en) | 2010-01-19 | 2014-04-15 | Verinata Health, Inc. | Partition defined detection methods |
| US20120100548A1 (en) | 2010-10-26 | 2012-04-26 | Verinata Health, Inc. | Method for determining copy number variations |
| WO2011090556A1 (en) | 2010-01-19 | 2011-07-28 | Verinata Health, Inc. | Methods for determining fraction of fetal nucleic acid in maternal samples |
| US10388403B2 (en) | 2010-01-19 | 2019-08-20 | Verinata Health, Inc. | Analyzing copy number variation in the detection of cancer |
| US9260745B2 (en) | 2010-01-19 | 2016-02-16 | Verinata Health, Inc. | Detecting and classifying copy number variation |
| US10662474B2 (en) | 2010-01-19 | 2020-05-26 | Verinata Health, Inc. | Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing |
| US9323888B2 (en) | 2010-01-19 | 2016-04-26 | Verinata Health, Inc. | Detecting and classifying copy number variation |
| EP3006573B1 (en) * | 2010-01-19 | 2018-03-07 | Verinata Health, Inc | Methods for determining fraction of fetal nucleic acids in maternal samples |
| US20110312503A1 (en) | 2010-01-23 | 2011-12-22 | Artemis Health, Inc. | Methods of fetal abnormality detection |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
| US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| EP2854057B1 (en) | 2010-05-18 | 2018-03-07 | Natera, Inc. | Methods for non-invasive pre-natal ploidy calling |
| CA2802111A1 (en) * | 2010-07-23 | 2012-01-26 | Esoterix Genetic Laboratories, Llc | Identification of differentially represented fetal or maternal genomic regions and uses thereof |
| US8700338B2 (en) | 2011-01-25 | 2014-04-15 | Ariosa Diagnosis, Inc. | Risk calculation for evaluation of fetal aneuploidy |
| US20140342940A1 (en) | 2011-01-25 | 2014-11-20 | Ariosa Diagnostics, Inc. | Detection of Target Nucleic Acids using Hybridization |
| US11203786B2 (en) | 2010-08-06 | 2021-12-21 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
| US11031095B2 (en) | 2010-08-06 | 2021-06-08 | Ariosa Diagnostics, Inc. | Assay systems for determination of fetal copy number variation |
| US20120034603A1 (en) | 2010-08-06 | 2012-02-09 | Tandem Diagnostics, Inc. | Ligation-based detection of genetic variants |
| US20130040375A1 (en) | 2011-08-08 | 2013-02-14 | Tandem Diagnotics, Inc. | Assay systems for genetic analysis |
| US10167508B2 (en) | 2010-08-06 | 2019-01-01 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities |
| US10533223B2 (en) | 2010-08-06 | 2020-01-14 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
| US20130261003A1 (en) | 2010-08-06 | 2013-10-03 | Ariosa Diagnostics, In. | Ligation-based detection of genetic variants |
| EP4269623A3 (en) | 2010-11-30 | 2024-03-06 | The Chinese University Of Hong Kong | Analysis of a biological sample of an organism for chromosomal deletions or amplifications associated with cancer |
| WO2012078792A2 (en) * | 2010-12-07 | 2012-06-14 | Stanford University | Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale |
| CA2821906C (en) | 2010-12-22 | 2020-08-25 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US8756020B2 (en) * | 2011-01-25 | 2014-06-17 | Ariosa Diagnostics, Inc. | Enhanced risk probabilities using biomolecule estimations |
| US9994897B2 (en) | 2013-03-08 | 2018-06-12 | Ariosa Diagnostics, Inc. | Non-invasive fetal sex determination |
| WO2012103031A2 (en) * | 2011-01-25 | 2012-08-02 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities |
| US10131947B2 (en) | 2011-01-25 | 2018-11-20 | Ariosa Diagnostics, Inc. | Noninvasive detection of fetal aneuploidy in egg donor pregnancies |
| US11270781B2 (en) | 2011-01-25 | 2022-03-08 | Ariosa Diagnostics, Inc. | Statistical analysis for non-invasive sex chromosome aneuploidy determination |
| JP6153874B2 (ja) | 2011-02-09 | 2017-06-28 | ナテラ， インコーポレイテッド | 非侵襲的出生前倍数性呼び出しのための方法 |
| JP2014506465A (ja) | 2011-02-09 | 2014-03-17 | バイオ−ラド ラボラトリーズ，インコーポレイティド | 核酸の分析 |
| EP2678451B1 (en) | 2011-02-24 | 2017-04-26 | The Chinese University Of Hong Kong | Molecular testing of multiple pregnancies |
| DK2697392T3 (en) * | 2011-04-12 | 2016-03-29 | Verinata Health Inc | SOLUTION OF GENOME FRACTIONS USING Polymorphism COUNTS |
| GB2484764B (en) | 2011-04-14 | 2012-09-05 | Verinata Health Inc | Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies |
| US9411937B2 (en) | 2011-04-15 | 2016-08-09 | Verinata Health, Inc. | Detecting and classifying copy number variation |
| US20140235474A1 (en) | 2011-06-24 | 2014-08-21 | Sequenom, Inc. | Methods and processes for non invasive assessment of a genetic variation |
| US8880456B2 (en) | 2011-08-25 | 2014-11-04 | Complete Genomics, Inc. | Analyzing genome sequencing information to determine likelihood of co-segregating alleles on haplotypes |
| US8712697B2 (en) | 2011-09-07 | 2014-04-29 | Ariosa Diagnostics, Inc. | Determination of copy number variations using binomial probability calculations |
| US9367663B2 (en) | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US20140242588A1 (en) | 2011-10-06 | 2014-08-28 | Sequenom, Inc | Methods and processes for non-invasive assessment of genetic variations |
| US9984198B2 (en) | 2011-10-06 | 2018-05-29 | Sequenom, Inc. | Reducing sequence read count error in assessment of complex genetic variations |
| US10424394B2 (en) | 2011-10-06 | 2019-09-24 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US10196681B2 (en) | 2011-10-06 | 2019-02-05 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| HUE059847T2 (hu) | 2012-01-20 | 2023-01-28 | Sequenom Inc | Kísérleti körülményeket fakturáló diagnosztikai folyamatok |
| US9238836B2 (en) | 2012-03-30 | 2016-01-19 | Pacific Biosciences Of California, Inc. | Methods and compositions for sequencing modified nucleic acids |
| WO2013130848A1 (en) * | 2012-02-29 | 2013-09-06 | Natera, Inc. | Informatics enhanced analysis of fetal samples subject to maternal contamination |
| EP3401399B1 (en) * | 2012-03-02 | 2020-04-22 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| PL2851431T3 (pl) | 2012-05-14 | 2018-04-30 | Bgi Genomics Co., Ltd. | Sposób, system i odczytywalny komputerowo nośnik do określania informacji o zasadach we wcześniej określonym obszarze genomu płodu |
| US10289800B2 (en) | 2012-05-21 | 2019-05-14 | Ariosa Diagnostics, Inc. | Processes for calculating phased fetal genomic sequences |
| US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
| US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2013177581A2 (en) * | 2012-05-24 | 2013-11-28 | University Of Washington Through Its Center For Commercialization | Whole genome sequencing of a human fetus |
| US11261494B2 (en) | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
| US10497461B2 (en) | 2012-06-22 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| JP2015521862A (ja) * | 2012-07-13 | 2015-08-03 | セクエノム， インコーポレイテッド | 非侵襲性の出生前診断に有用な母体サンプル由来の胎児核酸のメチル化に基づく富化のためのプロセスおよび組成物 |
| CN104619863A (zh) * | 2012-07-13 | 2015-05-13 | 生命技术公司 | 采用一组snp的人身份识别 |
| JP2015522293A (ja) | 2012-07-19 | 2015-08-06 | アリオサ ダイアグノスティックス インコーポレイテッドＡｒｉｏｓａ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． | 多重化連続ライゲーションに基づく遺伝子変異体の検出 |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| US20140065621A1 (en) * | 2012-09-04 | 2014-03-06 | Natera, Inc. | Methods for increasing fetal fraction in maternal blood |
| CA2883245A1 (en) * | 2012-09-06 | 2014-03-13 | Ancestry.Com Dna, Llc | Using haplotypes to infer ancestral origins for recently admixed individuals |
| US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
| US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
| WO2014043763A1 (en) * | 2012-09-20 | 2014-03-27 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
| US10482994B2 (en) * | 2012-10-04 | 2019-11-19 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9213947B1 (en) | 2012-11-08 | 2015-12-15 | 23Andme, Inc. | Scalable pipeline for local ancestry inference |
| US9977708B1 (en) | 2012-11-08 | 2018-05-22 | 23Andme, Inc. | Error correction in ancestry classification |
| US10643738B2 (en) * | 2013-01-10 | 2020-05-05 | The Chinese University Of Hong Kong | Noninvasive prenatal molecular karyotyping from maternal plasma |
| EP4414990A3 (en) | 2013-01-17 | 2024-11-06 | Personalis, Inc. | Methods and systems for genetic analysis |
| US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| KR102241051B1 (ko) | 2013-02-28 | 2021-04-16 | 더 차이니즈 유니버시티 오브 홍콩 | 대량 동시 rna 서열분석에 의한 모체 혈장 전사물 분석 |
| EP3597774A1 (en) | 2013-03-13 | 2020-01-22 | Sequenom, Inc. | Primers for dna methylation analysis |
| JP2016518811A (ja) * | 2013-03-15 | 2016-06-30 | ザ チャイニーズ ユニバーシティ オブ ホンコン | 多胎妊娠における胎児ゲノムの決定 |
| WO2014165596A1 (en) | 2013-04-03 | 2014-10-09 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CN105189787A (zh) * | 2013-05-09 | 2015-12-23 | 豪夫迈·罗氏有限公司 | 使用hla标志物测定母体血液中的胎儿dna的分数的方法 |
| WO2014190286A2 (en) | 2013-05-24 | 2014-11-27 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| DK3011051T3 (en) | 2013-06-21 | 2019-04-23 | Sequenom Inc | Method for non-invasive evaluation of genetic variations |
| US20150004601A1 (en) * | 2013-06-28 | 2015-01-01 | Ariosa Diagnostics, Inc. | Massively parallel sequencing of random dna fragments for determination of fetal fraction |
| GB201318369D0 (en) * | 2013-10-17 | 2013-12-04 | Univ Leuven Kath | Methods using BAF |
| EP3039161B1 (en) | 2013-08-30 | 2021-10-06 | Personalis, Inc. | Methods and systems for genomic analysis |
| US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
| US9499870B2 (en) * | 2013-09-27 | 2016-11-22 | Natera, Inc. | Cell free DNA diagnostic testing standards |
| US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
| GB2535066A (en) | 2013-10-03 | 2016-08-10 | Personalis Inc | Methods for analyzing genotypes |
| KR102514024B1 (ko) | 2013-10-04 | 2023-03-23 | 시쿼넘, 인코포레이티드 | 유전적 변이의 비침습 평가를 위한 방법 및 프로세스 |
| CN111863131A (zh) | 2013-10-07 | 2020-10-30 | 塞昆纳姆股份有限公司 | 用于非侵入性评估染色体改变的方法和过程 |
| WO2015138774A1 (en) | 2014-03-13 | 2015-09-17 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US12492429B2 (en) | 2014-04-21 | 2025-12-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| AU2015249846B2 (en) | 2014-04-21 | 2021-07-22 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| US20180173845A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| US10119167B2 (en) | 2014-07-18 | 2018-11-06 | Illumina, Inc. | Non-invasive prenatal diagnosis of fetal genetic condition using cellular DNA and cell free DNA |
| US20160026759A1 (en) * | 2014-07-22 | 2016-01-28 | Yourgene Bioscience | Detecting Chromosomal Aneuploidy |
| WO2016015058A2 (en) | 2014-07-25 | 2016-01-28 | University Of Washington | Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same |
| ES3047391T3 (en) | 2014-07-30 | 2025-12-03 | Sequenom Inc | Methods and processes for non-invasive assessment of genetic variations |
| CN104182655B (zh) * | 2014-09-01 | 2017-03-08 | 上海美吉生物医药科技有限公司 | 一种判断胎儿基因型的方法 |
| CN104232778B (zh) * | 2014-09-19 | 2016-08-17 | 天津华大基因科技有限公司 | 同时确定胎儿单体型及染色体非整倍性的方法及装置 |
| US10612080B2 (en) * | 2014-09-22 | 2020-04-07 | Roche Molecular Systems, Inc. | Digital PCR for non-invasive prenatal testing |
| EP3212808B1 (en) | 2014-10-30 | 2022-03-02 | Personalis, Inc. | Methods for using mosaicism in nucleic acids sampled distal to their origin |
| CN105648045B (zh) * | 2014-11-13 | 2019-10-11 | 天津华大基因科技有限公司 | 确定胎儿目标区域单体型的方法和装置 |
| CN105648044B (zh) * | 2014-11-13 | 2019-10-11 | 天津华大基因科技有限公司 | 确定胎儿目标区域单体型的方法和装置 |
| CN104561309B (zh) * | 2015-01-04 | 2017-04-19 | 北京积水潭医院 | 一种来自人辅助生殖囊胚植入前进行出生安全性预测的试剂盒 |
| CN104561311B (zh) * | 2015-01-04 | 2016-08-17 | 北京大学第三医院 | 一种来自人辅助生殖胚胎发育早期出生安全性预测的试剂盒 |
| US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
| WO2016112539A1 (zh) * | 2015-01-16 | 2016-07-21 | 深圳华大基因股份有限公司 | 确定胎儿核酸含量的方法和装置 |
| SG11201706529TA (en) * | 2015-02-10 | 2017-09-28 | Univ Hong Kong Chinese | Detecting mutations for cancer screening and fetal analysis |
| US10424396B2 (en) * | 2015-03-27 | 2019-09-24 | Sentieon Inc. | Computation pipeline of location-dependent variant calls |
| EP3294906B1 (en) | 2015-05-11 | 2024-07-10 | Natera, Inc. | Methods for determining ploidy |
| CN107922971A (zh) * | 2015-05-18 | 2018-04-17 | 凯锐思公司 | 用于富集核酸群体的组合物和方法 |
| CN107922959A (zh) * | 2015-07-02 | 2018-04-17 | 阿瑞玛基因组学公司 | 混合物样品的精确分子去卷积 |
| EP3325663B1 (en) | 2015-07-20 | 2020-08-19 | The Chinese University Of Hong Kong | Methylation pattern analysis of haplotypes in tissues in dna mixture |
| DK3325664T3 (da) | 2015-07-23 | 2022-03-07 | Univ Hong Kong Chinese | Analyse af fragmenteringsmønstre for cellefrit DNA |
| TWI793586B (zh) | 2015-08-12 | 2023-02-21 | 香港中文大學 | 血漿dna之單分子定序 |
| TWI858334B (zh) | 2015-09-22 | 2024-10-11 | 香港中文大學 | 藉由母體血漿ｄｎａ之淺深度測序以準確定量胎兒dna含量 |
| GB201518665D0 (en) | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for enrichment of cell free nucleosomes |
| CN105335625B (zh) * | 2015-11-04 | 2018-02-16 | 和卓生物科技（上海）有限公司 | 胚胎植入前的遗传学检测装置 |
| WO2017181202A2 (en) | 2016-04-15 | 2017-10-19 | Natera, Inc. | Methods for lung cancer detection |
| CN105926043B (zh) * | 2016-04-19 | 2018-08-28 | 苏州贝康医疗器械有限公司 | 一种提高孕妇血浆游离dna测序文库中胎儿游离dna占比的方法 |
| WO2017193044A1 (en) * | 2016-05-06 | 2017-11-09 | Counsyl, Inc. | Noninvasive prenatal diagnostic |
| US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
| WO2018003220A1 (ja) * | 2016-06-29 | 2018-01-04 | トヨタ自動車株式会社 | Ｄｎａライブラリーの作製方法及びｄｎａライブラリーを用いたゲノムｄｎａ解析方法 |
| EP3491560A1 (en) | 2016-07-27 | 2019-06-05 | Sequenom, Inc. | Genetic copy number alteration classifications |
| EP3518974A4 (en) | 2016-09-29 | 2020-05-27 | Myriad Women's Health, Inc. | NON-INVASIVE PRENATAL SCREENING USING DYNAMIC ITERATIVE DEEP OPTIMIZATION |
| WO2018067517A1 (en) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
| TWI797095B (zh) | 2016-10-24 | 2023-04-01 | 美商格瑞爾有限責任公司 | 腫瘤檢測之方法及系統 |
| GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| TWI675918B (zh) * | 2016-11-18 | 2019-11-01 | 香港中文大學 | 基於單倍型之通用非侵入性單基因疾病產前檢測 |
| US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
| CA3207879A1 (en) | 2017-01-24 | 2018-08-02 | Sequenom, Inc. | Methods and processes for assessment of genetic variations |
| ES2990117T3 (es) | 2017-01-25 | 2024-11-28 | Univ Hong Kong Chinese | Aplicaciones de diagnóstico que utilizan fragmentos de ácido nucleico |
| EP3585889A1 (en) | 2017-02-21 | 2020-01-01 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
| EP3998350B1 (en) | 2017-03-17 | 2025-05-07 | Sequenom, Inc. | Methods and processes for assessment of genetic mosaicism |
| EP3602359A4 (en) | 2017-03-24 | 2021-01-06 | Myriad Women's Health, Inc. | NUMBER OF COPIES VARIANT CALLER |
| CN110915165B (zh) | 2017-05-12 | 2023-05-26 | 麻省理工学院 | 用于共享私有数据的计算机实现的方法和装置 |
| JP7056012B2 (ja) | 2017-05-19 | 2022-04-19 | トヨタ自動車株式会社 | ランダムプライマーセット、及びこれを用いたｄｎａライブラリーの作製方法 |
| KR102145417B1 (ko) * | 2017-05-24 | 2020-08-19 | 지니너스 주식회사 | 무세포 핵산으로부터 수득된 서열 분석 데이터에 대한 배경 대립인자의 빈도 분포를 생성하는 방법 및 이를 이용하여 무세포 핵산으로부터 변이를 검출하는 방법 |
| WO2019010410A1 (en) | 2017-07-07 | 2019-01-10 | Massachusetts Institute Of Technology | SYSTEMS AND METHODS OF GENETIC IDENTIFICATION AND ANALYSIS |
| JP7434143B2 (ja) * | 2017-07-12 | 2024-02-20 | アンディ・コーポレイション | パターン認識システム |
| CN109280697B (zh) * | 2017-07-20 | 2022-04-26 | 天昊生物医药科技（苏州）有限公司 | 利用孕妇血浆游离dna进行胎儿基因型鉴定的方法 |
| ES2959360T3 (es) | 2017-07-26 | 2024-02-23 | Univ Hong Kong Chinese | Mejora del cribado del cáncer mediante ácidos nucleicos víricos acelulares |
| US11646100B2 (en) | 2017-08-04 | 2023-05-09 | Billiontoone, Inc. | Target-associated molecules for characterization associated with biological targets |
| US11519024B2 (en) | 2017-08-04 | 2022-12-06 | Billiontoone, Inc. | Homologous genomic regions for characterization associated with biological targets |
| EP3662085B1 (en) | 2017-08-04 | 2022-06-22 | Billiontoone, Inc. | Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets |
| CN107545153B (zh) * | 2017-10-25 | 2021-06-11 | 桂林电子科技大学 | 一种基于卷积神经网络的核小体分类预测方法 |
| WO2019118926A1 (en) | 2017-12-14 | 2019-06-20 | Tai Diagnostics, Inc. | Assessing graft suitability for transplantation |
| JP7047373B2 (ja) | 2017-12-25 | 2022-04-05 | トヨタ自動車株式会社 | 次世代シーケンサー用プライマー並びにその製造方法、次世代シーケンサー用プライマーを用いたｄｎａライブラリー並びにその製造方法、及びｄｎａライブラリーを用いたゲノムｄｎａ解析方法 |
| PT3735470T (pt) | 2018-01-05 | 2024-01-31 | Billiontoone Inc | Modelos de controlo de qualidade para garantir a validade dos ensaios baseados em sequenciamento |
| WO2019161244A1 (en) | 2018-02-15 | 2019-08-22 | Natera, Inc. | Methods for isolating nucleic acids with size selection |
| CA3090426A1 (en) | 2018-04-14 | 2019-10-17 | Natera, Inc. | Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna |
| US20190341127A1 (en) * | 2018-05-03 | 2019-11-07 | The Chinese University Of Hong Kong | Size-tagged preferred ends and orientation-aware analysis for measuring properties of cell-free mixtures |
| US11814750B2 (en) | 2018-05-31 | 2023-11-14 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
| US10801064B2 (en) | 2018-05-31 | 2020-10-13 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| WO2020033425A1 (en) | 2018-08-06 | 2020-02-13 | Billiontoone, Inc. | Dilution tagging for quantification of biological targets |
| EP3847275A4 (en) * | 2018-09-03 | 2022-06-15 | Ramot at Tel-Aviv University Ltd. | METHOD AND SYSTEM FOR IDENTIFICATION OF GENE DISORDER IN MATERNAL BLOOD |
| EP3847653A2 (en) * | 2018-09-07 | 2021-07-14 | Illumina, Inc. | A method to determine if a circulating fetal cell isolated from a pregnant mother is from either the current or a historical pregnancy |
| CN113330121A (zh) | 2018-12-17 | 2021-08-31 | 纳特拉公司 | 用于循环细胞分析的方法 |
| CN109887548B (zh) * | 2019-01-18 | 2022-11-08 | 臻悦生物科技江苏有限公司 | 基于捕获测序的ctDNA占比的检测方法及检测装置 |
| CN111560424A (zh) * | 2019-02-13 | 2020-08-21 | 广州医科大学附属第一医院 | 可检测的目标核酸、探针、确定胎儿f8基因单体型的方法及应用 |
| AU2020246747A1 (en) | 2019-03-25 | 2021-08-26 | Grail, Inc. | Determining linear and circular forms of circulating nucleic acids |
| BR112021020684A2 (pt) * | 2019-04-22 | 2021-12-07 | Personal Genome Diagnostics Inc | Métodos e sistemas para análise genética |
| EP3980559A1 (en) | 2019-06-06 | 2022-04-13 | Natera, Inc. | Methods for detecting immune cell dna and monitoring immune system |
| US20210020266A1 (en) | 2019-07-19 | 2021-01-21 | 23Andme, Inc. | Phase-aware determination of identity-by-descent dna segments |
| PL3916105T3 (pl) * | 2019-08-14 | 2023-06-26 | Bgi Genomics Co., Limited | Metoda i urządzenie do oznaczania stężenia płodowego kwasu nukleinowego we krwi kobiety w ciąży |
| TWI832482B (zh) | 2019-08-16 | 2024-02-11 | 香港中文大學 | 核酸鹼基修飾的測定 |
| CN112466397A (zh) * | 2019-09-09 | 2021-03-09 | 深圳乐土生物科技有限公司 | 一种用于亲缘关系检测的方法和装置 |
| CN114945987A (zh) | 2019-11-05 | 2022-08-26 | 佩索纳里斯公司 | 从单一样品预估肿瘤纯度 |
| JP2023501006A (ja) * | 2019-11-18 | 2023-01-17 | エンバーク ヴェテリナリー，インコーポレーテッド | 祖先血縁を決定するための方法およびシステム |
| KR102662186B1 (ko) * | 2020-02-05 | 2024-05-07 | 더 차이니즈 유니버시티 오브 홍콩 | 임신 중 긴 세포유리 단편을 사용한 분자 분석 |
| CN111312332B (zh) * | 2020-02-13 | 2020-10-30 | 国家卫生健康委科学技术研究所 | 基于hla基因的生物信息处理方法、装置及终端 |
| US11817176B2 (en) | 2020-08-13 | 2023-11-14 | 23Andme, Inc. | Ancestry composition determination |
| US12322509B2 (en) * | 2020-11-08 | 2025-06-03 | The Johns Hopkins University | Methods and related aspects for analyzing chromosome number status |
| CN112575077A (zh) * | 2020-12-23 | 2021-03-30 | 东莞市妇幼保健院 | 一种胎儿显性遗传病新发突变的无创基因检测方法及应用 |
| CA3226132A1 (en) | 2021-04-22 | 2022-10-27 | Natera, Inc. | Methods for determining velocity of tumor growth |
| JP2024528932A (ja) | 2021-08-02 | 2024-08-01 | ナテラ， インコーポレイテッド | 妊娠中の女性における新生物を検出するための方法 |
| US12297508B2 (en) | 2021-10-05 | 2025-05-13 | Personalis, Inc. | Customized assays for personalized cancer monitoring |
| WO2023133131A1 (en) | 2022-01-04 | 2023-07-13 | Natera, Inc. | Methods for cancer detection and monitoring |
| CN119546780A (zh) | 2022-03-21 | 2025-02-28 | 十亿至一公司 | 用于治疗监测的甲基化无细胞dna的分子计数 |
| WO2025208288A1 (zh) * | 2024-04-01 | 2025-10-09 | 深圳华大生命科学研究院 | 基因预测方法、装置、计算机设备及计算机可读存储介质 |
| CN119007813B (zh) * | 2024-09-29 | 2025-11-07 | 漳州片仔癀药业股份有限公司 | 一种基于mtDNA的高海拔饲养林麝的种源鉴定及遴选方法 |
| CN120412715B (zh) * | 2025-03-17 | 2025-11-28 | 上海蓝沙生物科技有限公司 | 一种通过多态性位点连锁区域块评估孕期母本游离血液中胎儿DNA浓度（cffDNA）的方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078999A1 (en) * | 2003-03-05 | 2004-09-16 | Genetic Technologies Limited | Identification of fetal dna and fetal cell markers in maternal plasma or serum |
| WO2007100911A2 (en) * | 2006-02-28 | 2007-09-07 | University Of Louisville Research Foundation | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
| WO2009013492A1 (en) * | 2007-07-23 | 2009-01-29 | The Chinese University Of Hong Kong | Determining a nucleic acid sequence imbalance |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704444D0 (en) | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
| US6664056B2 (en) * | 2000-10-17 | 2003-12-16 | The Chinese University Of Hong Kong | Non-invasive prenatal monitoring |
| US6927028B2 (en) | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
| IL163600A0 (en) | 2002-03-01 | 2005-12-18 | Ravgen Inc | Methods for detection of genetic disorders |
| US6977162B2 (en) * | 2002-03-01 | 2005-12-20 | Ravgen, Inc. | Rapid analysis of variations in a genome |
| RU2200761C1 (ru) | 2002-04-01 | 2003-03-20 | Московский НИИ педиатрии и детской хирургии | Набор рекомбинантных плазмидных днк рyai 11-19, рyai 2-45, рys 37 и рyai 7-29 для определения происхождения добавочных или маркерных (мини-) хромосом человека |
| US20070178478A1 (en) * | 2002-05-08 | 2007-08-02 | Dhallan Ravinder S | Methods for detection of genetic disorders |
| US7727720B2 (en) * | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
| JP2006521086A (ja) | 2003-02-28 | 2006-09-21 | ラブジェン， インコーポレイテッド | 遺伝子疾患の検出方法 |
| ATE435301T1 (de) | 2003-10-16 | 2009-07-15 | Sequenom Inc | Nicht invasiver nachweis fötaler genetischer merkmale |
| AU2006224971B2 (en) | 2005-03-18 | 2009-07-02 | Boston University | A method for the detection of chromosomal aneuploidies |
| US20070122823A1 (en) | 2005-09-01 | 2007-05-31 | Bianchi Diana W | Amniotic fluid cell-free fetal DNA fragment size pattern for prenatal diagnosis |
| GB0523276D0 (en) * | 2005-11-15 | 2005-12-21 | London Bridge Fertility | Chromosomal analysis by molecular karyotyping |
| EP2423334A3 (en) | 2006-02-02 | 2012-04-18 | The Board of Trustees of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
| US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
| US12180549B2 (en) * | 2007-07-23 | 2024-12-31 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using genomic sequencing |
| CA3116156C (en) * | 2008-08-04 | 2023-08-08 | Natera, Inc. | Methods for allele calling and ploidy calling |
| JP2012513217A (ja) | 2008-12-22 | 2012-06-14 | セルラ・インコーポレイテッド | 対立遺伝子、ゲノムおよびトランスクリプトームを検出する方法および遺伝子型決定パネル |
| WO2011057094A1 (en) | 2009-11-05 | 2011-05-12 | The Chinese University Of Hong Kong | Fetal genomic analysis from a maternal biological sample |
| AU2010317019B2 (en) * | 2009-11-06 | 2014-10-30 | The Chinese University Of Hong Kong | Size-based genomic analysis |
| US9260745B2 (en) | 2010-01-19 | 2016-02-16 | Verinata Health, Inc. | Detecting and classifying copy number variation |
| EP2854057B1 (en) | 2010-05-18 | 2018-03-07 | Natera, Inc. | Methods for non-invasive pre-natal ploidy calling |
| WO2012103031A2 (en) | 2011-01-25 | 2012-08-02 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities |
| EP2678451B1 (en) | 2011-02-24 | 2017-04-26 | The Chinese University Of Hong Kong | Molecular testing of multiple pregnancies |
| JP2016518811A (ja) | 2013-03-15 | 2016-06-30 | ザ チャイニーズ ユニバーシティ オブ ホンコン | 多胎妊娠における胎児ゲノムの決定 |
-
2010
- 2010-11-05 WO PCT/US2010/055655 patent/WO2011057094A1/en not_active Ceased
- 2010-11-05 PT PT107824682T patent/PT2496717T/pt unknown
- 2010-11-05 TW TW099138291A patent/TWI458976B/zh active
- 2010-11-05 EA EA201200690A patent/EA033752B1/ru unknown
- 2010-11-05 FI FIEP20200970.0T patent/FI3783110T3/fi active
- 2010-11-05 ES ES10782468.2T patent/ES2628874T3/es active Active
- 2010-11-05 PT PT17168527T patent/PT3241914T/pt unknown
- 2010-11-05 RS RS20190421A patent/RS58879B1/sr unknown
- 2010-11-05 HR HRP20230134TT patent/HRP20230134T1/hr unknown
- 2010-11-05 PL PL20200970.0T patent/PL3783110T3/pl unknown
- 2010-11-05 PL PL10782468T patent/PL2496717T3/pl unknown
- 2010-11-05 HU HUE10782468A patent/HUE034854T2/en unknown
- 2010-11-05 SI SI201032126T patent/SI3783110T1/sl unknown
- 2010-11-05 EP EP10782468.2A patent/EP2496717B1/en active Active
- 2010-11-05 AU AU2010315037A patent/AU2010315037B9/en active Active
- 2010-11-05 DK DK20200970.0T patent/DK3783110T3/da active
- 2010-11-05 HU HUE20200970A patent/HUE061110T2/hu unknown
- 2010-11-05 EP EP17168527.4A patent/EP3241914B1/en active Active
- 2010-11-05 ES ES20200970T patent/ES2934941T3/es active Active
- 2010-11-05 EP EP19153788.5A patent/EP3498863B1/en active Active
- 2010-11-05 DK DK17168527.4T patent/DK3241914T3/en active
- 2010-11-05 PL PL17168527T patent/PL3241914T3/pl unknown
- 2010-11-05 EP EP20200970.0A patent/EP3783110B1/en active Active
- 2010-11-05 EP EP22198296.0A patent/EP4170043A1/en active Pending
- 2010-11-05 MX MX2012005214A patent/MX2012005214A/es active IP Right Grant
- 2010-11-05 MX MX2013011466A patent/MX355132B/es unknown
- 2010-11-05 SI SI201031876T patent/SI3241914T1/sl unknown
- 2010-11-05 CN CN201080059486.6A patent/CN102770558B/zh active Active
- 2010-11-05 DK DK10782468.2T patent/DK2496717T3/en active
- 2010-11-05 RS RS20230090A patent/RS63944B1/sr unknown
- 2010-11-05 SM SM20190229T patent/SMT201900229T1/it unknown
- 2010-11-05 BR BR112012010694A patent/BR112012010694B8/pt active IP Right Grant
- 2010-11-05 SM SM20230034T patent/SMT202300034T1/it unknown
- 2010-11-05 PT PT202009700T patent/PT3783110T/pt unknown
- 2010-11-05 US US12/940,993 patent/US8467976B2/en active Active
- 2010-11-05 LT LTEP17168527.4T patent/LT3241914T/lt unknown
- 2010-11-05 CA CA2779695A patent/CA2779695C/en active Active
- 2010-11-05 CN CN201610127207.4A patent/CN105779280B/zh active Active
- 2010-11-05 ES ES17168527T patent/ES2720282T3/es active Active
- 2010-11-05 LT LTEP20200970.0T patent/LT3783110T/lt unknown
- 2010-11-05 HU HUE17168527A patent/HUE043574T2/hu unknown
- 2010-11-05 JP JP2012538035A patent/JP5540105B2/ja active Active
-
2012
- 2012-05-01 IL IL219521A patent/IL219521A/en active IP Right Grant
- 2012-05-03 MX MX2022004800A patent/MX2022004800A/es unknown
-
2013
- 2013-05-15 US US13/895,304 patent/US10093976B2/en active Active
- 2013-05-15 US US13/895,308 patent/US9512480B2/en active Active
-
2014
- 2014-05-01 JP JP2014094667A patent/JP6023117B2/ja active Active
-
2015
- 2015-02-10 IL IL237175A patent/IL237175A/en active IP Right Grant
- 2015-02-11 IL IL237179A patent/IL237179A/en active IP Right Grant
-
2016
- 2016-06-13 JP JP2016117179A patent/JP6386494B2/ja active Active
-
2018
- 2018-06-07 US US16/002,468 patent/US11401551B2/en active Active
-
2019
- 2019-03-28 HR HRP20190601TT patent/HRP20190601T1/hr unknown
- 2019-06-05 CY CY20191100593T patent/CY1122003T1/el unknown
-
2022
- 2022-06-14 US US17/840,409 patent/US20220325344A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078999A1 (en) * | 2003-03-05 | 2004-09-16 | Genetic Technologies Limited | Identification of fetal dna and fetal cell markers in maternal plasma or serum |
| WO2007100911A2 (en) * | 2006-02-28 | 2007-09-07 | University Of Louisville Research Foundation | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
| WO2009013492A1 (en) * | 2007-07-23 | 2009-01-29 | The Chinese University Of Hong Kong | Determining a nucleic acid sequence imbalance |
Non-Patent Citations (6)
| Title |
|---|
| CHIU ROSSA W K ET AL: "Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 105, no. 51, 23 December 2008 (2008-12-23), pages 20458 - 20463, XP002620454, ISSN: 0027-8424, DOI: 10.1073/pnas.0810641105 * |
| CHIU, R.W.K. ; CANTOR, C.R. ; LO, Y.M.D.: "Non-invasive prenatal diagnosis by single molecule counting technologies", TRENDS IN GENETICS., ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM., NL, vol. 25, no. 7, 1 July 2009 (2009-07-01), NL, pages 324 - 331, XP026301457, ISSN: 0168-9525, DOI: 10.1016/j.tig.2009.05.004 * |
| DING CHUNMING ET AL: "MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 101, no. 29, 20 July 2004 (2004-07-20), pages 10762 - 10767, XP002614099, ISSN: 0027-8424, DOI: 10.1073/pnas.0403962101 * |
| FAN H.C., ET AL: "Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 105, no. 42, 21 October 2008 (2008-10-21), pages 16266 - 16271, XP002613056, ISSN: 0027-8424, DOI: 10.1073/pnas.0808319105 * |
| FIONA M. F. LUN, NANCY B. Y. TSUI, K. C. ALLEN CHAN, TAK Y. LEUNG, TZE K. LAU, PIMLAK CHAROENKWAN, KATHERINE C. K. CHOW, WYATT Y. : "Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 105, no. 50, 16 December 2008 (2008-12-16), pages 19920 - 19925, XP002620453, ISSN: 0027-8424, DOI: 10.1073/pnas.0810373105 * |
| REED W ET AL: "Non-invasive determination of the paternal HLA haplotype of a fetus using kinetic PCR to detect fetal microchimerism in maternal plasma", BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, GB, vol. 29, no. 6, 2 March 2002 (2002-03-02), GB, pages 527 - 529, XP002424270, ISSN: 0268-3369, DOI: 10.1038/sj.bmt.1703411 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220325344A1 (en) | Identifying a de novo fetal mutation from a maternal biological sample | |
| HK40092153A (en) | Fetal genomic analysis from a maternal biological sample | |
| AU2013203446B2 (en) | Identifying a de novo fetal mutation from a maternal biological sample | |
| HK40047861A (en) | Fetal genomic analysis from a maternal biological sample | |
| HK40047861B (en) | Fetal genomic analysis from a maternal biological sample | |
| HK40007427B (en) | Fetal genomic analysis from a maternal biological sample | |
| HK40007427A (en) | Fetal genomic analysis from a maternal biological sample | |
| EA050163B1 (ru) | Анализ генома плода из материнского биологического образца | |
| EA040939B1 (ru) | Анализ генома плода из материнского биологического образца | |
| HK1222413B (zh) | 由母本生物样品进行胎儿基因组的分析 | |
| HK1239754A1 (en) | Fetal genomic analysis from a maternal biological sample | |
| HK1175504B (en) | Fetal genomic analysis from a maternal biological sample | |
| HK1175504A (en) | Fetal genomic analysis from a maternal biological sample | |
| BR122020014914B1 (pt) | Métodos para identificar uma mutação de novo no genoma de um feto não nascido de uma fêmea grávida, para determinar uma concentração fracionária de dna fetal em uma amostra biológica tirada de uma fêmea grávida e para determinar uma proporção de um genoma fetal que foi sequenciado a partir de uma amostra biológica tirada de uma fêmea grávida, e, meio legível por computador não transitório | |
| HK1239754B (en) | Fetal genomic analysis from a maternal biological sample |